Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zinc Supplementation in Prediabetes
NCT05835037Phase 4Recruiting
- Sponsor
- University of Maryland, Baltimore
- Start
- Feb 2024
- Primary completion
- Jul 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of zinc gluconate in prediabetes (2 arms), sponsored by University of Maryland, Baltimore. Primary endpoints: Fasting Plasma Glucose at 1 year and Hemoglobin A1c at 1 year. Started Feb 2024; status: recruiting.
02
Drugs
zinc gluconate
03
Conditions
prediabetes
Beyond the preview
Go deeper on NCT05835037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05835037.